CITIGROUP INC - TRILLIUM THERAPEUTICS INC ownership

TRILLIUM THERAPEUTICS INC's ticker is and the CUSIP is 89620X506. A total of 137 filers reported holding TRILLIUM THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.33 and the average weighting 0.4%.

Quarter-by-quarter ownership
CITIGROUP INC ownership history of TRILLIUM THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$634,000
+1052.7%
36,104
+538.3%
0.00%
Q2 2021$55,000
+400.0%
5,656
+465.6%
0.00%
Q1 2021$11,000
-26.7%
1,0000.0%0.00%
Q4 2020$15,000
+50.0%
1,000
+42.9%
0.00%
Q3 2020$10,000
+11.1%
700
-36.4%
0.00%
Q2 2020$9,000
+800.0%
1,100
+2015.4%
0.00%
Q2 2015$1,000520.00%
Other shareholders
TRILLIUM THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
VR Adviser, LLC 4,040,000$59,428,0008.74%
Fairmount Funds Management LLC 1,478,181$21,744,0007.78%
COMMODORE CAPITAL LP 852,871$12,546,0006.82%
Ghost Tree Capital, LLC 1,950,000$28,685,0006.39%
Endurant Capital Management LP 655,741$9,646,0003.48%
FRAZIER MANAGEMENT LLC 3,053,107$44,879,0003.46%
ACUTA CAPITAL PARTNERS, LLC 803,000$11,812,0003.21%
NEA Management Company, LLC 5,736,363$84,382,0002.23%
Tri Locum Partners LP 296,838$4,366,0001.59%
Avidity Partners Management LP 3,185,200$46,854,0001.52%
View complete list of TRILLIUM THERAPEUTICS INC shareholders